BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25425965)

  • 21. PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex.
    Alves MM; Fuhler GM; Queiroz KC; Scholma J; Goorden S; Anink J; Spek CA; Hoogeveen-Westerveld M; Bruno MJ; Nellist M; Elgersma Y; Aronica E; Peppelenbosch MP
    Sci Rep; 2015 Sep; 5():14534. PubMed ID: 26412398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex.
    Rensing N; Han L; Wong M
    Epilepsia; 2015 Jul; 56(7):1088-97. PubMed ID: 26122303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.
    Cornu M; Oppliger W; Albert V; Robitaille AM; Trapani F; Quagliata L; Fuhrer T; Sauer U; Terracciano L; Hall MN
    Proc Natl Acad Sci U S A; 2014 Aug; 111(32):11592-9. PubMed ID: 25082895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential.
    Kim S; Lahmy R; Riha C; Yang C; Jakubison BL; van Niekerk J; Staub C; Wu Y; Gates K; Dong DS; Konieczny SF; Itkin-Ansari P
    Pancreas; 2015 Jul; 44(5):718-27. PubMed ID: 25894862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner.
    Zou J; Zhang B; Gutmann DH; Wong M
    Epilepsia; 2017 Dec; 58(12):2053-2063. PubMed ID: 29023667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells.
    Benhamron S; Tirosh B
    Eur J Immunol; 2011 Aug; 41(8):2390-6. PubMed ID: 21674478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.
    Aguilar S; Corominas JM; Malats N; Pereira JA; Dufresne M; Real FX; Navarro P
    Am J Pathol; 2004 Oct; 165(4):1129-39. PubMed ID: 15466380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice.
    Abs E; Goorden SM; Schreiber J; Overwater IE; Hoogeveen-Westerveld M; Bruinsma CF; Aganović E; Borgesius NZ; Nellist M; Elgersma Y
    Ann Neurol; 2013 Oct; 74(4):569-79. PubMed ID: 23720219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC; Klimstra DS; Varmus HE
    Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.
    Yang H; Wang X; Zhang Y; Liu H; Liao J; Shao K; Chu Y; Liu G
    J Cell Physiol; 2014 Jan; 229(1):17-26. PubMed ID: 23804073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific disruption of Tsc1 in ovarian granulosa cells promotes ovulation and causes progressive accumulation of corpora lutea.
    Huang L; Wang ZB; Jiang ZZ; Hu MW; Lin F; Zhang QH; Luo YB; Hou Y; Zhao Y; Fan HY; Schatten H; Sun QY
    PLoS One; 2013; 8(1):e54052. PubMed ID: 23335988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells.
    Magini A; Polchi A; Di Meo D; Mariucci G; Sagini K; De Marco F; Cassano T; Giovagnoli S; Dolcetta D; Emiliani C
    Hum Mol Genet; 2017 Sep; 26(17):3303-3312. PubMed ID: 28637240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
    Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
    Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical roles for the TSC-mTOR pathway in β-cell function.
    Mori H; Inoki K; Opland D; Münzberg H; Villanueva EC; Faouzi M; Ikenoue T; Kwiatkowski DJ; Macdougald OA; Myers MG; Guan KL
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1013-22. PubMed ID: 19690069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
    Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
    J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice.
    Magdalon J; Chimin P; Belchior T; Neves RX; Vieira-Lara MA; Andrade ML; Farias TS; Bolsoni-Lopes A; Paschoal VA; Yamashita AS; Kowaltowski AJ; Festuccia WT
    Biochim Biophys Acta; 2016 May; 1861(5):430-8. PubMed ID: 26923434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ectopic expression of neurogenin 3 in neonatal pig pancreatic precursor cells induces (trans)differentiation to functional alpha cells.
    Harb G; Heremans Y; Heimberg H; Korbutt GS
    Diabetologia; 2006 Aug; 49(8):1855-63. PubMed ID: 16736130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-specific ablation of Tsc1 in pancreatic beta-cells.
    Mori H; Guan KL
    Methods Mol Biol; 2012; 821():407-19. PubMed ID: 22125081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The TSC1-mTOR-PLK axis regulates the homeostatic switch from Schwann cell proliferation to myelination in a stage-specific manner.
    Jiang M; Rao R; Wang J; Wang J; Xu L; Wu LM; Chan JR; Wang H; Lu QR
    Glia; 2018 Sep; 66(9):1947-1959. PubMed ID: 29722913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.